KUHS Third Professional MBBS Degree Part I Examination 303001 September 2014 Community Medicine-Paper I Question Paper

303001 September 2014 Common to munity Medicine-Paper I

Q.P. Code: 303001 Reg. no.: ???????
Third Professional MBBS (Part I) Supplementary Degree Examinations,
September 2014
Community Medicine-Paper I
Time: 3 Hours Total Marks: 60
? Answer all questions
? Draw diagrams wherever necessary
Essay: (10)1. Sanjana is a recent MBBS graduate who is working as a medical officer in a primary
health centre. There a number of patients present to her with signs of jaundice. A local
traditional medical practitioner tells her about the usefulness of a special plant in the
treatment of jaundice. She decides to test plant. Answer the following:
? What type of study design should she use ? What are the steps of such a study
? How she will analyze the data, that she has gathered (2+4+4=10)Problems: (2×5=10)2. As a medical officer of a primary health centre what are the steps that you will take to
investigate the outbreak of food-poisoning following a village festival
3. What are the critical factors that you will consider, when taking the history of a 40 years
old male whose BMI is 28.5, who presents to you at an annual medical check-up
conducted by his company
Short answer Question: (5×4=20)4. Dietary goals recommended by WHO experts
5. Effects of noise exposure
6. Third generation IUCDs
7. Causes of sickness absenteeism
8. Symptoms of drug addiction
Differentiate between: (3×2=6)9. Pre-employment medical check and periodic medical check
10. Early expanding stage and late expanding stage in the demographic cycle
11. Isolation and quarantine
Substantiate your answer with reasons: (2×2=4)12. Exclusive breastfeeding is imperative for the young infant
13. Medic-social worker is an important part of the health team
List the following: (5×2=10)14. Criteria for judging causality
15. Specific protection methods
16. Indicators used in the calculation of human development index
17. Steps in a case-control study
18. Drugs used in category II of tuberculosis treatment
*******************